Significance of S100A8, S100A9 and calprotectin levels in bladder cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Scandinavian Journal of Clinical and Laboratory Investigation

• Publication date

  2017-06-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00365513.2017.1336567PMID 28609200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic potential of YKL-40 in bladder cancer.

  2016cited by this paper
• Biomarkers in melanoma

  2016cited by this paper
• Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt

  2016cited by this paper
• Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer

  2015cited by this paper
• Urinary Calprotectin and Posttransplant Renal Allograft Injury

  2014cited by this paper
• Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder

  2014cited by this paper
• Low- and high-grade bladder cancer appraisal via serum-based proteomics approach.

  2014cited by this paper
• Epidemiology and risk factors of urothelial bladder cancer.

  2013cited by this paper
• Urinary markers for bladder cancer

  2013cited by this paper
• [Expression and clinical significance of calcium-binding protein S100A9 in breast cancer].

  2012cited by this paper
• Pro-Inflammatory S100A8 and S100A9 Proteins: Self-Assembly into Multifunctional Native and Amyloid Complexes

  2012cited by this paper
• [Changes in calprotectin concentration--inflammation marker in serum of women with gynecological cancer].

  2011cited by this paper
• Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury.

  2011cited by this paper
• The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

  2009cited by this paper
• Biomarkers in melanoma

  2009cited by this paper
• Identification of S100A8 and S100A9 as serological markers for colorectal cancer.

  2009cited by this paper
• The present and future burden of urinary bladder cancer in the world

  2009cited by this paper
• Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancer.

  2008cited by this paper
• Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary.

  2008cited by this paper
• RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis

  2008cited by this paper
• A review of the S100 proteins in cancer.

  2008cited by this paper
• The S100 proteins for screening and prognostic grading of bladder cancer.

  2007cited by this paper
• Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells

  2007cited by this paper
• Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate Cancer

  2005cited by this paper
• Probing the S100 protein family through genomic and functional analysis.

  2004cited by this paper
• Urinary markers in bladder cancer

  2003cited by this paper

• In Search of Ideal Solutions for Cancer Diagnosis: From Conventional Methods to Protein Biomarkers in Liquid Biopsy

  2025cites this paper
• Differential Expression of S100A8 in Tumor and Immune Compartments of Endometrial Carcinoma and Its Clinical Relevance

  2025cites this paper
• ITRAQ and PRM-based quantitative saliva proteomics in gastric cancer: biomarker discovery

  2025cites this paper
• Nano optical (bio)sensing platforms for early detection of pediatric cancer

  2025cites this paper
• Current look at the most promising proteomic and glycomic biomarkers of bladder cancer

  2024cites this paper
• Pro-inflammatory S100A8 Protein Exhibits a Detergent-like Effect on Anionic Lipid Bilayers, as Imaged by High-Speed AFM

  2024cites this paper
• Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer

  2024cites this paper
• The Receptor for Advanced Glycation Endproducts (RAGE) and Its Ligands S100A8/A9 and High Mobility Group Box Protein 1 (HMGB1) Are Key Regulators of Myeloid-Derived Suppressor Cells

  2023cites this paper
• Glioma-derived S100A9 polarizes M2 microglia to inhibit CD8+T lymphocytes for immunosuppression via αvβ3 integrin/AKT1/TGFβ1.

  2023cites this paper
• Development of a prognostic signature for immune-associated genes in bladder cancer and exploring potential drug findings

  2023cites this paper
• A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer

  2023cites this paper
• S100A9 plays a key role in Clostridium perfringens beta2 toxin-induced inflammatory damage in porcine IPEC-J2 intestinal epithelial cells

  2023cites this paper
• Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study

  2022cites this paper
• S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases

  2022cites this paper
• Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis.

  2022cites this paper
• WWOX Loses the Ability to Regulate Oncogenic AP-2γ and Synergizes with Tumor Suppressor AP-2α in High-Grade Bladder Cancer

  2021cites this paper
• S100 family members: potential therapeutic target in patients with hepatocellular carcinoma

  2021cites this paper
• Calprotectin: from biomarker to biological function

  2021cites this paper
• Blood-based protein biomarkers in bladder urothelial tumors.

  2021cites this paper
• High expression of S100A8 and S100A9 is associated with poor disease-free survival in patients with cancer: a systematic review and meta-analysis

  2021cites this paper
• Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K/Akt Signaling Pathway

  2021cites this paper
• Evidence of immunogenic cancer cell death induced by honey-processed Astragalus polysaccharides in vitro and in vivo.

  2021cites this paper
• The clinical efficacy of extended-field radiation therapy for locally advanced cervical cancer combined with regional lymph node metastasis and its effect on the serum levels of TNF-α and S100A8

  2020cites this paper
• Top-down and bottom-up proteomics of circulating S100A8/S100A9 in plasma of septic shock patients.

  2020cites this paper
• Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.

  2020cites this paper
• Prognostic Role of S100A8 in Human Solid Cancers: A Systematic Review and Validation

  2020cites this paper
• Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.

  2020cites this paper
• Intracellular and extracellular S100A9 trigger epithelial-mesenchymal transition and promote the invasive phenotype of pituitary adenoma through activation of AKT1

  2020cites this paper
• Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial

  2020cites this paper
• Ca2+-Binding Proteins of the EF-Hand Superfamily: Diagnostic and Prognostic Biomarkers and Novel Therapeutic Targets.

  2019cites this paper
• S100 proteins: Diagnostic and prognostic biomarkers in laboratory medicine.

  2019cites this paper
• Fecal calprotectin and colorectal cancer

  2019cites this paper
• The significance of calprotectin, CD147, APOA4 and DJ-1 in non-invasive detection of urinary bladder carcinoma.

  2019cites this paper
• The value of mRNA expression of S100A8 and S100A9 as blood-based biomarkers of inflammatory bowel disease.

  2019cites this paper
• Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response

  2019cites this paper
• Proteome‐based classification of Nonmuscle Invasive Bladder Cancer

  2019cites this paper
• Circular RNA circMAN2B2 facilitates glioma progression by regulating the miR‐1205/S100A8 axis

  2019cites this paper
• Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung

  2018cites this paper
• Multiplex Immuno-MALDI-TOF MS for Targeted Quantification of Protein Biomarkers and Their Proteoforms Related to Inflammation and Renal Dysfunction.

  2018cites this paper
• Screening and identification of key biomarkers in bladder carcinoma: Evidence from bioinformatics analysis

  2018cites this paper